24 May 2013
Keywords: fda, panel, backs, safety, b-ms/az, onglyza, expert
Article | 02 April 2009
An expert panel convened by the US Food and Drug Administration has voted 10 to two that data on type 2 diabetes ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 April 2009
23 May 2013
© 2013 thepharmaletter.com